Streetwise Tools & Diagnostics Articles



Telemedicine Co. Sees Record Revenues on Software, Services Sales
Source: Streetwise Reports  (3/13/23)
Reliq Health Technologies Inc. reports that software and services revenue continues to increase, leading to record cash intake for the quarter that ended Dec. 31, 2022. More >


AI-Infused Telehealth Platform Absorbs New Patients
Source: Streetwise Reports  (2/22/23)
Telemedicine company Reliq Health Technologies Inc., which uses artificial intelligence in its software's algorithms, has gained six new contracts and more than 3,000 new patients. More >


Former Investment Officer of One of the World's Largest Sovereign Wealth Funds Shares His Current Focus
Source: Streetwise Reports  (1/25/23)
Streetwise Reports sat down with Øyvind Schanke, the chief investment officer of TD Veen and the former investment officer of one of the world's largest sovereign wealth funds as he shares his current focus. More >


Telehealth Co. Expects More Growth in 2023
Source: Streetwise Reports  (1/20/23)
Officials at telemedicine company Reliq Health Technologies say they expect to accelerate growth "significantly" in 2023, which could lead to a share buyback program. More >


Expert Says Health Tech Co. Still in Good Spot To Buy
Source: Clive Maund  (11/28/22)
Technical analyst Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you whether he believes it is a Buy. More >


Organ Transplant Co.'s Q3 Revenues Rise 378%
Source: Streetwise Reports  (11/4/22)
Shares of medical technology firm TransMedics Group Inc. traded 24% higher to a new 52-week high after the company reported Q3/22 financial results highlighting a 378% YoY increase in net revenue and raised its FY/22 revenue estimates to US$80-85 million. More >


Telemedicine Co. Surges on Revenue News
Source: Streetwise Reports  (11/4/22)
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar. More >


Robotic Surgical Device Co.'s Shares Rise on Q3 Earnings
Source: Streetwise Reports  (10/20/22)
Shares of Intuitive Surgical Inc. traded 9% higher yesterday after the robotic surgical device maker reported Q3/22 earnings that included an 11% YoY increase in revenue and a 13% YoY increase in its installed da Vinci Surgical System base. More >


Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World
Source: Streetwise Reports  (9/21/22)
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc. More >


US Co. To Regain All Rights to Its AGHD Diagnostic Test
Source: Dr. Ram Selvaraju  (9/8/22)
This is set to happen because the biopharma's commercialization partner recently terminated its agreement over the product, noted an H.C. Wainwright & Co. report. More >


Expert Expects Life Science Co. To Do Exceptionally Well
Source: Penny Queen  (8/15/22)
Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.
More >


Diagnostics Co. Secures Global Deal for Resistant Bacteria ID Kit
Source: Streetwise Reports  (8/15/22)
Accelerate Diagnostics Inc. shares traded 25% higher after the company reported Q2/22 earnings and announced it entered into a commercial agreement with Becton, Dickinson and Co. that will allow it to deliver rapid antimicrobial identification and susceptibility diagnostics to clinicians and patients worldwide. More >


MRI Device Maker's Earnings Come In at High End of Forecasts
Source: Streetwise Reports  (8/3/22)
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40). More >


Biomedical Firms Merger Makes Programming Cells Easier
Source: Streetwise Reports  (7/26/22)
Shares of Zymergen Inc. traded 16% higher after the company reported it agreed to be acquired by Ginkgo Bioworks Inc. in an all-stock transaction valued at $300 million. More >


Monkeypox Virus Test Could Yield Revenue for Its Creator
  (5/31/22)
The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report. More >


FDA Approves New Skin Resurfacing Device
Source: Streetwise Reports  (5/26/22)
Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures. More >


Ophthalmic Med Tech. Firm Sees 166% Gain in LAL Implants
Source: Streetwise Reports  (5/6/22)
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDDâ„¢s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery." More >


Is Reliq Health Technologies a Nutrimental 'Buy'?
Source: Clive Maund  (4/29/22)
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'. More >


Co. to Rebound After Q4/21 Sales Down Due to Virus Surge
  (3/1/22)
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report. More >


Imaging Diagnostics Co.'s Shares Rise 35% on FY21 Earnings
Source: Streetwise Reports  (2/24/22)
Lantheus Holdings Inc. shares traded to a new 52-week high after the firm reported Q4/21 and FY/21 financial results that included a 25.3% increase in annual revenue. The firm also advised that the FDA approved the sNDA for its isolator-based drug manufacturing facility for diagnostic ultrasound enhancing agent DEFINITY® for patients in the U.S. with suboptimal echocardiograms. More >


Dialysis Equip. Co. Posts Record FY21 Sales
Source: Streetwise Reports  (2/17/22)
Shares of a wireless mobile dialysis equipment maker traded 15% higher after the company reported FY/21 financial results highlighting a 105% YoY increase in revenue to $102.6 million. More >


FDA Approves First Tubeless Insulin Delivery Device
Source: Streetwise Reports  (1/28/22)
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone. More >


Biotech Could Launch Trial of Polyp Screening Test in March
  (1/18/22)
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report. More >


Co.'s COVID-19 Test Detects Omicron Variant
  (12/30/21)
H.C. Wainwright & Co. gives Sorrento Therapeutics a Buy rating after initial testing shows its COVISTIX detects COVID-19's Omicron variant. More >


Contakt World Technologies Partnership Will Help Satisfy Demand for Vaccine Passport Technology
Source: Streetwise Reports  (11/12/21)
Contakt World plans to build a diversified health technology SaaS platform and address inequity of health access through technology. More >


Showing Results: 26 to 50 of 351 Prev Next

Notable Quotes

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts